Major discrepancy between factual antibiotic resistance and consumption in South of France: analysis of 539,037 bacterial strains.
Acinetobacter baumannii
/ drug effects
Anti-Bacterial Agents
/ therapeutic use
Bacteria
/ classification
Databases, Factual
/ statistics & numerical data
Drug Resistance, Bacterial
Escherichia coli
/ drug effects
France
Humans
Microbial Sensitivity Tests
/ methods
Models, Theoretical
Pseudomonas aeruginosa
/ drug effects
Retrospective Studies
Staphylococcus aureus
/ drug effects
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
26 10 2020
26 10 2020
Historique:
received:
17
01
2020
accepted:
21
04
2020
entrez:
27
10
2020
pubmed:
28
10
2020
medline:
13
3
2021
Statut:
epublish
Résumé
The burden of antibiotic resistance is currently estimated by mathematical modeling, without real count of resistance to key antibiotics. Here we report the real rate of resistance to key antibiotics in bacteria isolated from humans during a 5 years period in a large area in southeast in France. We conducted a retrospective study on antibiotic susceptibility of 539,107 clinical strains isolated from hospital and private laboratories in south of France area from January 2014 to January 2019. The resistance rate to key antibiotics as well as the proportion of bacteria classified as Difficult-to-Treat (DTR) were determined and compared with the Mann-Whitney U test, the χ
Identifiants
pubmed: 33106494
doi: 10.1038/s41598-020-75158-7
pii: 10.1038/s41598-020-75158-7
pmc: PMC7588456
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
18262Références
Nat Rev Microbiol. 2010 Apr;8(4):260-71
pubmed: 20208551
Emerg Infect Dis. 2017 Apr;23(4):582-589
pubmed: 28322712
Clin Infect Dis. 2017 Aug 15;65(suppl_1):S58-S63
pubmed: 28859341
Int J Antimicrob Agents. 2016 Apr;47(4):249
pubmed: 27026226
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Nature. 2011 Aug 31;477(7365):457-61
pubmed: 21881561
Clin Infect Dis. 2019 Oct 15;69(9):1641
pubmed: 30838399
Lancet Infect Dis. 2019 Jan;19(1):4-6
pubmed: 30409682
Antimicrob Agents Chemother. 2011 Mar;55(3):1222-8
pubmed: 21220537
Front Microbiol. 2013 Jun 24;4:173
pubmed: 23805136
PLoS Med. 2016 Nov 29;13(11):e1002184
pubmed: 27898664
Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):395-407
pubmed: 30515637
Crit Care. 2016 Jul 11;20(1):221
pubmed: 27417949
Lancet Infect Dis. 2018 Oct;18(10):1138-1149
pubmed: 30126643
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1687-1697
pubmed: 29956024
Lancet Infect Dis. 2019 Feb;19(2):128-129
pubmed: 30722996
Euro Surveill. 2019 May;24(20):
pubmed: 31115312
Clin Microbiol Infect. 2015 Jun;21(6):569.e1-7
pubmed: 25704445
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Clin Infect Dis. 2018 Nov 28;67(12):1803-1814
pubmed: 30052813
Emerg Infect Dis. 2015 Aug;21(8):1302-10
pubmed: 26196165
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683